INTEGRATED MICRONEEDLE ARRAY DELIVERY SYSTEM

(19)

(11)

EP 2 766 066 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	20.01.2021 Bulletin 2021/03

(45)	Mention of the grant of the patent:
	02.12.2020 Bulletin 2020/49

(21)	Application number: 12840675.8

(22)	Date of filing: 09.10.2012

(51)

International Patent Classification (IPC):

A61M 5/00^(2006.01)

A61M 37/00^(2006.01)

(86)	International application number:
	PCT/US2012/059273

(87)	International publication number:
	WO 2013/055638 (18.04.2013 Gazette 2013/16)

(54)	INTEGRATED MICRONEEDLE ARRAY DELIVERY SYSTEM INTEGRIERTES ABGABESYSTEM FÜR MIKRONADELANORDNUNGEN SYSTÈME DE POSE D'UN ENSEMBLE DE MICRO-AIGUILLES INTÉGRÉES

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

12.10.2011 US 201161546340 P

(43)	Date of publication of application:
	20.08.2014 Bulletin 2014/34

(73)	Proprietor: Kindeva Drug Delivery L.P.
	St. Paul, MN 55170 (US)

(72)	Inventors:
	COLBURN, David J. Saint Paul, Minnesota 55133-3427 (US) JOHNSON, Erik J. Oakdale, Minnesota 55128 (US) BRANDWEIN, David H. Saint Paul, Minnesota 55133-3427 (US) GYSBERS, Jerome E. Saint Paul, Minnesota 55133-3427 (US) YOUNG, Patrick J. Saint Paul, Minnesota 55133-3427 (US) CANTOR, Adam S. Saint Paul, Minnesota 55133-3427 (US)

(74)	Representative: Vossius & Partner Patentanwälte Rechtsanwälte mbB
	Siebertstrasse 3 81675 München 81675 München (DE)

(56)

References cited: :

WO-A1-2007/124411
US-A1- 2008 114 298
US-A1- 2009 198 189
US-A1- 2010 222 743
US-B2- 7 097 631

WO-A1-2011/014514
US-A1- 2008 208 146
US-A1- 2009 254 041
US-A1- 2011 172 645

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).